Inventor · disambiguated record
Sanjeev Satyal
Also filed as: SATYAL SANJEEV · SATYAL SANJEEV H
33 granted patents·13 pending applications·406 citations·filing 2004–2020
97Inventor score
Files withONCOMED PHARM INC24PH PHARMA CO LTD6GURNEY AUSTIN4AMGEN MOUNTAIN VIEW INC2GURNEY AUSTIN L2
Top patents by PatentIndex Score
46 records- 0198US7982013B2Frizzled-binding agents and uses thereofONCOMED PHARM INC·Filed 2009·Granted Jul 19, 2011·41 cites·28 claims
- 0298US7723477B2Compositions and methods for inhibiting Wnt-dependent solid tumor cell growthONCOMED PHARM INC·Filed 2006·Granted May 25, 2010·40 cites·40 claims
- 0397US8507442B2Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8GURNEY AUSTIN L·Filed 2011·Granted Aug 13, 2013·44 cites·21 claims
- 0496US7750124B2Anti-human DLL4 antibodies and compositionsONCOMED PHARM INC·Filed 2007·Granted Jul 6, 2010·46 cites·13 claims
- 0595US7919092B2Antibodies to notch receptorsONCOMED PHARM INC·Filed 2007·Granted Apr 5, 2011·27 cites·21 claims
- 0694US9573998B2Antibodies against human FZD5 and FZD8ONCOMED PHARM INC·Filed 2015·Granted Feb 21, 2017·7 cites·14 claims
- 0794US8324361B2Nucleic acid molecules encoding soluble frizzled (FZD) receptorsGURNEY AUSTIN·Filed 2010·Granted Dec 4, 2012·11 cites·45 claims
- 0894US7803907B2c-MET kinase binding proteinsAMGEN MOUNTAIN VIEW INC·Filed 2005·Granted Sep 28, 2010·53 cites·19 claims
- 0993US8206713B2Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2LEWICKI JOHN A·Filed 2011·Granted Jun 26, 2012·21 cites·21 claims
- 1092US9376497B2Compositions and methods for diagnosing and treating cancerGURNEY AUSTIN·Filed 2010·Granted Jun 28, 2016·16 cites·14 claims
- 1192US9228020B2Compositions and methods for diagnosing and treating cancerONCOMED PHARM INC·Filed 2013·Granted Jan 5, 2016·14 cites·32 claims
- 1292US8975044B2Polynucleotides encoding for frizzled-binding agents and uses thereofONCOMED PHARM INC·Filed 2013·Granted Mar 10, 2015·7 cites·20 claims
- 1392US8404237B2Antibodies to the NOTCH1 receptorLEWICKI JOHN A·Filed 2012·Granted Mar 26, 2013·15 cites·19 claims
- 1491US7968681B2c-MET kinase binding proteinsAMGEN MOUNTAIN VIEW INC·Filed 2010·Granted Jun 28, 2011·11 cites·6 claims
- 1590US8765913B2Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer and inhibiting growth of tumor cellsONCOMED PHARM INC·Filed 2012·Granted Jul 1, 2014·9 cites·65 claims
- 1689US9273139B2Monoclonal antibodies against frizzledONCOMED PHARM INC·Filed 2013·Granted Mar 1, 2016·5 cites·18 claims
- 1787US9228013B2Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cellONCOMED PHARM INC·Filed 2014·Granted Jan 5, 2016·3 cites·12 claims
- 1887US8802103B2Compositions and methods for diagnosing and treating cancerGURNEY AUSTIN·Filed 2008·Granted Aug 12, 2014·5 cites·14 claims
- 1987US8784811B2Method of treating cancer using antibodies to a non-ligand binding region of NOTCH1ONCOMED PHARM INC·Filed 2013·Granted Jul 22, 2014·6 cites·18 claims
- 2086US9157904B2Wnt antagonists and methods of treatment and screeningSATYAL SANJEEV H·Filed 2011·Granted Oct 13, 2015·6 cites·6 claims
- 2186US8420885B2Determining the capability of a test compound to affect solid tumor stem cellsCLARKE MICHAEL F·Filed 2011·Granted Apr 16, 2013·5 cites·33 claims
- 2282US9850311B2Compositions and methods for diagnosing and treating cancerGURNEY AUSTIN·Filed 2006·Granted Dec 26, 2017·4 cites·11 claims
- 2380US8652843B2DDR1-binding agents and methods of use thereofGURNEY AUSTIN L·Filed 2009·Granted Feb 18, 2014·2 cites·13 claims
- 2478US9732139B2Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptorONCOMED PHARM INC·Filed 2015·Granted Aug 15, 2017·1 cites·28 claims
- 2578US9579361B2Wnt antagonist and methods of treatment and screeningONCOMED PHARM INC·Filed 2015·Granted Feb 28, 2017·1 cites·35 claims
- 2677US8044259B2Determining the capability of a test compound to affect solid tumor stem cellsUNIV MICHIGAN·Filed 2007·Granted Oct 25, 2011·4 cites·32 claims
- 2775US9676865B2Antibodies to a non-ligand binding region of at least two NOTCH receptorsONCOMED PHARM INC·Filed 2014·Granted Jun 13, 2017·1 cites·12 claims
- 2875US9206256B2DDR1-binding agents and methods of use thereofONCOMED PHARM INC·Filed 2014·Granted Dec 8, 2015·1 cites·22 claims
- 2968US10815246B2Thailanstatin analogsPH PHARMA CO LTD·Filed 2019·Granted Oct 27, 2020·0 cites·17 claims
- 3066US11691982B2Thailanstatin analogsPH PHARMA CO LTD·Filed 2020·Granted Jul 4, 2023·0 cites·9 claims
- 3166US10806735B2Use of neutrophil elastase inhibitors in liver diseasePH PHARMA CO LTD·Filed 2019·Granted Oct 20, 2020·0 cites·4 claims
- 3266US8652472B2Compositions and methods for diagnosing and treating cancerLEWICKI JOHN·Filed 2007·Granted Feb 18, 2014·0 cites·13 claims
- 3366US2018094040A1Compositions and Methods for Diagnosing and Treating CancerONCOMED PHARM INC·Filed 2017·Application pending·0 cites
- 3463US2019060453A1Compositions and Methods for Diagnosing and Treating CancerONCOMED PHARM INC·Filed 2018·Application pending·0 cites
- 3562US2016326259A1Frizzled-binding agents and uses thereofONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 3662US2014186342A1Compositions and Methods for Diagnosing and Treating CancerONCOMED PHARM INC·Filed 2014·Application pending·0 cites
- 3761US2017218041A1Wnt Antagonists and Methods of Treatment and ScreeningONCOMED PHARM INC·Filed 2017·Application pending·0 cites
- 3858US2021069192A1Use of neutrophil elastase inhibitors in liver diseasePH PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3957US10301319B2Thailanstatin analogsPH PHARMA CO LTD·Filed 2018·Granted May 28, 2019·0 cites·4 claims
- 4056US2016367667A1Compositions and Methods for Diagnosing and Treating CancerONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 4154US2013295106A1Frizzled-Binding Agents And Uses ThereofONCOMED PHARM INC·Filed 2013·Application pending·0 cites
- 4253US2006008844A1c-Met kinase binding proteinsAVIDIA RES INST·Filed 2004·Application pending·0 cites
- 4351US2017234854A1Frizzled-binding agents and uses thereofONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 4450US2018222997A1Compositions and methods for diagnosing and treating cancerONCOMED PHARM INC·Filed 2017·Application pending·0 cites
- 4548US2022296597A1Use of a neutrophil elastase inhibitor in lung diseasePH PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 4643US2008199423A1Methods of Using Apo2l Receptor Agonists and Ink Cell ActivatorsGENENTECH INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →